NWM
GSK icon

Northcape Wealth Management’s GSK GSK Stock Holding History

Northcape Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,847
Closed -$387K – 147
2023
Q2 		$387K Sell
10,847
-827
-7% -$29.7K 0.14% 113
2023
Q1 		$415K Buy
+11,674
New +$408K 0.15% 108
2022
Q4 		– Sell
-14,024
Closed -$413K – 97
2022
Q3 		$413K Buy
14,024
+1,659
+13% +$62.9K 0.15% 100
2022
Q2 		$673K Sell
12,365
-1,662
-12% -$91.8K 0.26% 73
2022
Q1 		$764K Buy
14,027
+4,702
+50% +$255K 0.22% 83
2021
Q4 		$514K Buy
+9,325
New +$485K 0.17% 81

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northcape Wealth Management's GSK Position: Q3 2023 in Review

Northcape Wealth Management sold out of GSK (GSK) in Q3 2023, closing a stake of 10,847 shares — an estimated $387K sold.

Northcape Wealth Management first reported a position in GSK in Q4 2021 and held it in 6 quarters. The position peaked at $764K in Q1 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Northcape Wealth Management reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • Northcape Wealth Management sold 10,847 GSK shares in Q3 2023, an estimated $387K.
  • Northcape Wealth Management first reported a position in GSK in Q4 2021 and held it in 6 quarters.
  • Northcape Wealth Management's GSK position peaked at $764K in Q1 2022.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Northcape Wealth Management's 13F filing for Q3 2023, filed 6 Nov 2023.